Pulmonary delivery of siRNA as a novel treatment for lung diseases.

Graphical abstract.

[1]  J. Alvarado,et al.  A comprehensive review of recent developments in falling-film, spray, bubble and microchannel absorbers for absorption systems , 2021, Renewable and Sustainable Energy Reviews.

[2]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[3]  Arun V. Kolanjiyil,et al.  Mice-to-men comparison of inhaled drug-aerosol deposition and clearance , 2019, Respiratory Physiology & Neurobiology.

[4]  Angus P R Johnston,et al.  The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery. , 2018, Bioconjugate chemistry.

[5]  J. Chen,et al.  Nucleic Acid-Based Therapeutics for Pulmonary Diseases , 2018, AAPS PharmSciTech.

[6]  Sheridan M. Hoy.  Patisiran: First Global Approval , 2018, Drugs.

[7]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[8]  Angus P R Johnston,et al.  Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles. , 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[9]  A. Iyer,et al.  siRNA Delivery Strategies: A Comprehensive Review of Recent Developments , 2017, Nanomaterials.

[10]  M. Lindsay,et al.  Clinical potential of oligonucleotide-based therapeutics in the respiratory system. , 2017, Pharmacology & therapeutics.

[11]  J. Lam,et al.  Delivery of RNAi Therapeutics to the Airways—From Bench to Bedside , 2016, Molecules.

[12]  W. Hinrichs,et al.  Pulmonary administration of small interfering RNA: The route to go? , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[13]  A. Thakur,et al.  Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[14]  M. Chougule,et al.  Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems. , 2016, Kona : powder science and technology in Japan.

[15]  M. Merkel,et al.  Therapeutic delivery of RNA effectors: diseases affecting the respiratory system. , 2016, Die Pharmazie.

[16]  Animikh Ray,et al.  Recent Patents in Pulmonary Delivery of Macromolecules. , 2015, Recent patents on drug delivery & formulation.

[17]  Bulent Ozpolat,et al.  Preclinical and clinical development of siRNA-based therapeutics. , 2015, Advanced drug delivery reviews.

[18]  Deep Pooja,et al.  Nanomedicines for targeted delivery of etoposide to non-small cell lung cancer using transferrin functionalized nanoparticles , 2015 .

[19]  T. Kissel,et al.  siRNA delivery to the lung: what's new? , 2014, Advanced drug delivery reviews.

[20]  T. Kissel,et al.  Nonviral pulmonary delivery of siRNA. , 2012, Accounts of chemical research.

[21]  J. Lam,et al.  Pulmonary delivery of therapeutic siRNA , 2011, Advanced Drug Delivery Reviews.

[22]  A. Hickey,et al.  Immunological and toxicological implications of short-term studies in animals of pharmaceutical aerosol delivery to the lungs: relevance to humans. , 2001, Critical reviews in therapeutic drug carrier systems.